TYRA NASDAQ
Tyra Biosciences, Inc.
1W: -9.6%
1M: -11.6%
3M: +4.6%
YTD: +23.2%
1Y: +230.9%
3Y: +159.0%
$32.47
-0.55 (-1.67%)
Weekly Expected Move ±7.2%
$32
$34
$37
$40
$42
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026173
Institutions Holding
+29 vs prior
111.2%
Ownership
-81.64%
40
New
56
Increased
58
Reduced
32
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-05 | Rueb Yuliya | officer: vice president, finance (pao) | A-Grant/Award | 8,333 | $— | $0 | Filing |
| 2026-05-05 | Ashar Bhavesh | officer: chief operating officer | A-Grant/Award | 15,013 | $— | $0 | Filing |
| 2026-05-05 | Harris Todd | officer: president and ceo | A-Grant/Award | 79,000 | $— | $0 | Filing |
| 2026-05-05 | Fuhrman Alan | officer: chief financial officer | A-Grant/Award | 20,000 | $— | $0 | Filing |
| 2026-05-05 | Warner Douglas J | officer: chief medical officer | A-Grant/Award | 25,000 | $— | $0 | Filing |
| 2026-03-26 | KAPLAN GILLA | director | D-Sale to Issuer | 53,172 | $37.75 | $2.0M | Filing |
| 2026-03-25 | KAPLAN GILLA | director | S-Sale | 14,295 | $36.97 | $529K | Filing |
| 2026-03-13 | Fuhrman Alan | officer: chief financial officer | A-Grant/Award | 1,376 | $9.13 | $13K | Filing |
| 2026-02-12 | Bensen Daniel | officer: chief discovery officer | S-Sale | 5,872 | $33.37 | $196K | Filing |
| 2026-02-12 | Bensen Daniel | officer: chief discovery officer | S-Sale | 2,128 | $31.50 | $67K | Filing |
| 2026-01-12 | Bensen Daniel | officer: chief discovery officer | S-Sale | 1,017 | $29.08 | $30K | Filing |
| 2026-01-12 | Bensen Daniel | officer: chief discovery officer | S-Sale | 6,983 | $28.44 | $199K | Filing |
| 2025-12-19 | MORE ROBERT J | director | S-Sale | 10,000 | $25.00 | $250K | Filing |
| 2025-12-12 | Bensen Daniel | officer: chief discovery officer | S-Sale | 8,000 | $22.64 | $181K | Filing |
| 2025-11-21 | MORE ROBERT J | director | S-Sale | 246,871 | $20.25 | $5.0M | Filing |
| 2025-11-19 | Bensen Daniel | officer: chief operating officer | S-Sale | 49,956 | $16.32 | $815K | Filing |
| 2025-11-18 | Bensen Daniel | officer: chief operating officer | S-Sale | 75,633 | $16.07 | $1.2M | Filing |
| 2025-11-17 | Bensen Daniel | officer: chief operating officer | S-Sale | 1,500 | $17.07 | $26K | Filing |
| 2025-11-17 | Bensen Daniel | officer: chief operating officer | S-Sale | 18,572 | $16.11 | $299K | Filing |
| 2025-11-14 | Bensen Daniel | officer: chief operating officer | S-Sale | 110,228 | $16.02 | $1.8M | Filing |
| 2025-11-13 | Bensen Daniel | officer: chief operating officer | S-Sale | 1,111 | $16.00 | $18K | Filing |
| 2025-09-15 | Fuhrman Alan | officer: chief financial officer | A-Grant/Award | 701 | $9.13 | $6K | Filing |
| 2025-06-18 | KAPLAN GILLA | director | S-Sale | 9,568 | $9.78 | $94K | Filing |
| 2025-06-17 | KAPLAN GILLA | director | S-Sale | 10 | $10.35 | $104 | Filing |
| 2025-06-16 | RA Capital Healthcare Fund LP | director | P-Purchase | 11,813 | $10.13 | $120K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 12,198,625 | $467M | — | 2026-03-31 | Filing |
| FMR LLC | 7,747,648 | $297M | +7,735,085 | 2026-03-31 | Filing |
| JANUS HENDERSON GROUP PLC | 3,890,589 | $149M | +955,147 | 2026-03-31 | Filing |
| Alta Partners Management Company, L.P. | 3,823,425 | $146M | — | 2026-03-31 | Filing |
| FARALLON CAPITAL MANAGEMENT LLC | 3,580,818 | $137M | +1,514,000 | 2026-03-31 | Filing |
| TCG Crossover Management, LLC | 3,248,980 | $124M | +350,877 | 2026-03-31 | Filing |
| Commodore Capital LP | 2,475,000 | $95M | -900,000 | 2026-03-31 | Filing |
| BlackRock, Inc. | 2,217,929 | $85M | +131,506 | 2026-03-31 | Filing |
| Paradigm Biocapital Advisors LP | 2,054,991 | $79M | +2,054,991 | 2026-03-31 | Filing |
| Caligan Partners LP | 1,276,968 | $49M | +332,711 | 2026-03-31 | Filing |
| STATE STREET CORP | 1,216,078 | $47M | +466,615 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,125,970 | $43M | +1,125,970 | 2026-03-31 | Filing |
| Logos Global Management LP | 850,000 | $33M | +640,000 | 2026-03-31 | Filing |
| BARCLAYS PLC | 833,399 | $32M | +757,090 | 2026-03-31 | Filing |
| Canaan Partners XI LLC | 750,000 | $29M | -2,624,329 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 658,482 | $25M | +726 | 2026-03-31 | Filing |
| JENNISON ASSOCIATES LLC | 632,432 | $24M | +632,432 | 2026-03-31 | Filing |
| Sio Capital Management, LLC | 605,439 | $23M | +79,437 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 550,334 | $21M | +367,947 | 2026-03-31 | Filing |
| Balyasny Asset Management L.P. | 351,479 | $13M | -466,847 | 2026-03-31 | Filing |